Lonza to Buy Stake in Indian Firm?

Lonza is in discussions with pharmaceutical company Aptuit Laurus (Hyderabad, India), to acquire a majority stake in the Indian company, say press reports. The deal maybe valued at about Rs.3.5 billion-Rs.4.5 billion ($77 million-$99 million), reports add. Aptuit Laurus mainly produces active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals, and the company also provides various services including early-stage drug discovery, medicinal chemistry, drug product development and analytical services. Aptuit Laurus was formed in 2007 as a joint...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers